Related references
Note: Only part of the references are listed.Mechanism of initiation of aggregation of p53 revealed by Φ-value analysis
GuoZhen Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker et al.
NATURE (2013)
First-order rate-determining aggregation mechanism of p53 and its implications
GuoZhen Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition
Rainer Wilcken et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides
Andreas Vitalis et al.
BIOPHYSICAL CHEMISTRY (2011)
Interaction of the p53 DNA-Binding Domain with Its N-Terminal Extension Modulates the Stability of the p53 Tetramer
Eviatar Natan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Ligand binding to distinct states diverts aggregation of an amyloid-forming protein
Lucy A. Woods et al.
NATURE CHEMICAL BIOLOGY (2011)
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
Jie Xu et al.
NATURE CHEMICAL BIOLOGY (2011)
Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53
Sridharan Rajagopalan et al.
NUCLEIC ACIDS RESEARCH (2011)
Ultraslow oligomerization equilibria of p53 and its implications
Eviatar Natan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural evolution of p53, p63, and p73: Implication for heterotetramer formation
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Frank M. Boeckler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prion detection by an amyloid seeding assay
David W. Colby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Quaternary structures of tumor suppressor p53 and a specific p53-DNA complex
Henning Tidow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Y. Li et al.
ONCOGENE (2007)
Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains
Hwee Ching Ang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates
C Soto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
p73 can suppress the proliferation of cells that express mutant p53
AC Willis et al.
ONCOGENE (2003)
Physical interaction with human tumor-derived p53 mutants inhibits p63 activities
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers - Implications on the dominant negative effect
CD Nicholls et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism
L Nielsen et al.
BIOCHEMISTRY (2001)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect
MV Blagosklonny
FASEB JOURNAL (2000)
Physical and functional interaction between p53 mutants and different isoforms of p73
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
MC Marin et al.
NATURE GENETICS (2000)
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
AN Bullock et al.
ONCOGENE (2000)
Amyloid fibrillogenesis: themes and variations
JC Rochet et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2000)
Share Paper
